291 related articles for article (PubMed ID: 17488527)
1. N-glycan alterations are associated with drug resistance in human hepatocellular carcinoma.
Kudo T; Nakagawa H; Takahashi M; Hamaguchi J; Kamiyama N; Yokoo H; Nakanishi K; Nakagawa T; Kamiyama T; Deguchi K; Nishimura S; Todo S
Mol Cancer; 2007 May; 6():32. PubMed ID: 17488527
[TBL] [Abstract][Full Text] [Related]
2. Expression of ABC transporters in human hepatocyte carcinoma cells with cross-resistance to epirubicin and mitoxantrone.
Kamiyama N; Takagi S; Yamamoto C; Kudo T; Nakagawa T; Takahashi M; Nakanishi K; Takahashi H; Todo S; Iseki K
Anticancer Res; 2006; 26(2A):885-8. PubMed ID: 16619483
[TBL] [Abstract][Full Text] [Related]
3. Specific N-glycans of Hepatocellular Carcinoma Cell Surface and the Abnormal Increase of Core-α-1, 6-fucosylated Triantennary Glycan via N-acetylglucosaminyltransferases-IVa Regulation.
Nie H; Liu X; Zhang Y; Li T; Zhan C; Huo W; He A; Yao Y; Jin Y; Qu Y; Sun XL; Li Y
Sci Rep; 2015 Nov; 5():16007. PubMed ID: 26537865
[TBL] [Abstract][Full Text] [Related]
4. Mammalian α-1,6-Fucosyltransferase (FUT8) Is the Sole Enzyme Responsible for the N-Acetylglucosaminyltransferase I-independent Core Fucosylation of High-mannose N-Glycans.
Yang Q; Wang LX
J Biol Chem; 2016 May; 291(21):11064-71. PubMed ID: 27008861
[TBL] [Abstract][Full Text] [Related]
5. N-glycosylation by N-acetylglucosaminyltransferase IVa enhances the interaction of integrin β1 with vimentin and promotes hepatocellular carcinoma cell motility.
Yang D; Han F; Cai J; Sun H; Wang F; Jiang M; Zhang M; Yuan M; Zhou W; Li H; Yang L; Bai Y; Xiao L; Dong H; Cheng Q; Mao H; Zhou L; Wang R; Li Y; Nie H
Biochim Biophys Acta Mol Cell Res; 2023 Oct; 1870(7):119513. PubMed ID: 37295747
[TBL] [Abstract][Full Text] [Related]
6. Substrate Preference and Interplay of Fucosyltransferase 8 and N-Acetylglucosaminyltransferases.
Tseng TH; Lin TW; Chen CY; Chen CH; Lin JL; Hsu TL; Wong CH
J Am Chem Soc; 2017 Jul; 139(28):9431-9434. PubMed ID: 28678517
[TBL] [Abstract][Full Text] [Related]
7. Glycomic analysis of alpha-fetoprotein L3 in hepatoma cell lines and hepatocellular carcinoma patients.
Nakagawa T; Miyoshi E; Yakushijin T; Hiramatsu N; Igura T; Hayashi N; Taniguchi N; Kondo A
J Proteome Res; 2008 Jun; 7(6):2222-33. PubMed ID: 18479159
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of N-acetylglucosaminyltransferases III and V in human melanoma cells. Implications for MCAM N-glycosylation.
Bubka M; Link-Lenczowski P; Janik M; Pocheć E; Lityńska A
Biochimie; 2014 Aug; 103():37-49. PubMed ID: 24726881
[TBL] [Abstract][Full Text] [Related]
9. Enzymes for N-Glycan Branching and Their Genetic and Nongenetic Regulation in Cancer.
Kizuka Y; Taniguchi N
Biomolecules; 2016 Apr; 6(2):. PubMed ID: 27136596
[TBL] [Abstract][Full Text] [Related]
10. Alteration of N-glycan expression profile and glycan pattern of glycoproteins in human hepatoma cells after HCV infection.
Xiang T; Yang G; Liu X; Zhou Y; Fu Z; Lu F; Gu J; Taniguchi N; Tan Z; Chen X; Xie Y; Guan F; Zhang XL
Biochim Biophys Acta Gen Subj; 2017 May; 1861(5 Pt A):1036-1045. PubMed ID: 28229927
[TBL] [Abstract][Full Text] [Related]
11. N-acetylglucosaminyltransferase IVa regulates metastatic potential of mouse hepatocarcinoma cells through glycosylation of CD147.
Fan J; Wang S; Yu S; He J; Zheng W; Zhang J
Glycoconj J; 2012 Aug; 29(5-6):323-34. PubMed ID: 22736280
[TBL] [Abstract][Full Text] [Related]
12. Aberrant expression of N-acetylglucosaminyltransferase-IVa and IVb (GnT-IVa and b) in pancreatic cancer.
Ide Y; Miyoshi E; Nakagawa T; Gu J; Tanemura M; Nishida T; Ito T; Yamamoto H; Kozutsumi Y; Taniguchi N
Biochem Biophys Res Commun; 2006 Mar; 341(2):478-82. PubMed ID: 16434023
[TBL] [Abstract][Full Text] [Related]
13. Physiological and glycomic characterization of N-acetylglucosaminyltransferase-IVa and -IVb double deficient mice.
Takamatsu S; Antonopoulos A; Ohtsubo K; Ditto D; Chiba Y; Le DT; Morris HR; Haslam SM; Dell A; Marth JD; Taniguchi N
Glycobiology; 2010 Jan; 20(4):485-97. PubMed ID: 20015870
[TBL] [Abstract][Full Text] [Related]
14. Glycans and cancer: role of N-glycans in cancer biomarker, progression and metastasis, and therapeutics.
Taniguchi N; Kizuka Y
Adv Cancer Res; 2015; 126():11-51. PubMed ID: 25727145
[TBL] [Abstract][Full Text] [Related]
15. Developmental expression of the neuron-specific N-acetylglucosaminyltransferase Vb (GnT-Vb/IX) and identification of its in vivo glycan products in comparison with those of its paralog, GnT-V.
Lee JK; Matthews RT; Lim JM; Swanier K; Wells L; Pierce JM
J Biol Chem; 2012 Aug; 287(34):28526-36. PubMed ID: 22715095
[TBL] [Abstract][Full Text] [Related]
16. Relationship between metastasis-associated phenotypes and N-glycan structure of surface glycoproteins in human hepatocarcinoma cells.
Guo HB; Zhang Y; Chen HL
J Cancer Res Clin Oncol; 2001 Apr; 127(4):231-6. PubMed ID: 11315257
[TBL] [Abstract][Full Text] [Related]
17. Alterations in glycosyltransferases during myeloid and monocytoid differentiation of HL-60 cells.
Liu AH; Liu F; Li Z; Gu JX; Chen HL
Cell Biol Int; 1998; 22(7-8):545-50. PubMed ID: 10452822
[TBL] [Abstract][Full Text] [Related]
18. Blocking of N-acetylglucosaminyltransferase V induces cellular endoplasmic reticulum stress in human hepatocarcinoma 7,721 cells.
Fang H; Huang W; Xu YY; Shen ZH; Wu CQ; Qiao SY; Xu Y; Yu L; Chen HL
Cell Res; 2006 Jan; 16(1):82-92. PubMed ID: 16467879
[TBL] [Abstract][Full Text] [Related]
19. Ulinastatin reduces the resistance of liver cancer cells to epirubicin by inhibiting autophagy.
Song B; Bian Q; Shao CH; Li G; Liu AA; Jing W; Liu R; Zhang YJ; Zhou YQ; Hu XG; Jin G
PLoS One; 2015; 10(3):e0120694. PubMed ID: 25815885
[TBL] [Abstract][Full Text] [Related]
20. Kinetic properties and substrate specificities of two recombinant human N-acetylglucosaminyltransferase-IV isozymes.
Oguri S; Yoshida A; Minowa MT; Takeuchi M
Glycoconj J; 2006 Nov; 23(7-8):473-80. PubMed ID: 17006639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
